scholarly journals Achieving glycaemic control without weight gain, hypoglycaemia, or gastrointestinal adverse events in type 2 diabetes in the SUSTAIN clinical trial programme

2018 ◽  
Vol 20 (10) ◽  
pp. 2426-2434 ◽  
Author(s):  
J. Hans DeVries ◽  
Cyrus Desouza ◽  
Srikanth Bellary ◽  
Jeffrey Unger ◽  
Oluf K. H. Hansen ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Weight Gain ◽  
Glycaemic Control ◽  
Adverse Events ◽  
Clinical Trial Programme ◽  
Gastrointestinal Adverse Events

scholarly journals Liraglutide reverses pronounced insulin-associated weight gain, improves glycaemic control and decreases insulin dose in patients with type 2 diabetes: a 26 week, randomised clinical trial (ELEGANT)

Diabetologia ◽  
2014 ◽  
Vol 57 (9) ◽  
pp. 1812-1819 ◽  
Author(s):  
Helena M. de Wit ◽  
Gerald M. M. Vervoort ◽  
Henry J. Jansen ◽  
Wim J. C. de Grauw ◽  
Bastiaan E. de Galan ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Weight Gain ◽  
Glycaemic Control ◽  
Insulin Dose ◽  
Randomised Clinical Trial

scholarly journals Cardio-Metabolic Benefits of Walnuts in Type 2 Diabetes Mellitus: A Literature Review

2021 ◽  
pp. 111-124
Author(s):  
Valentine Y Njike ◽  
Genevieve Cecile Kela ◽  
Nisar Khan ◽  
Rockiy Ayettey ◽  
Maxime Tindong ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Risk Factors ◽  
Type 2 Diabetes ◽  
At Risk ◽  
Type 2 Diabetes Mellitus ◽  
Weight Gain ◽  
Glycaemic Control ◽  
Metabolic Risk Factors ◽  
Metabolic Risk

Diabetes and its complications are main causes of morbidity and mortality among adults in the USA. An increase in the number of individuals with diabetes is primarily attributed to changes in dietary patterns including increased consumption of obesogenic foods and beverages. Many individuals who are overweight and obese show signs of insulin resistance and are at increased risk of Type 2 diabetes mellitus (T2DM) and cardiovascular disease. Lifestyle interventions (i.e., physical activity and nutrition) are the cornerstone of T2DM management and prevention. Prior research attests to the health benefits of consuming nuts, which have a substantial amount of mono- and polyunsaturated fatty acids, for individuals at risk for or with T2DM, and walnuts appear to be particularly promising. Walnuts are rich in nutrients, minerals, antioxidants, and vitamins that can contribute to improved cardio-metabolic risk factors in individuals at risk for or with T2DM. This review assesses the cardio-metabolic benefits of walnuts in T2DM. The authors’ review indicates that the reported effects of walnuts on glycaemic control have been inconclusive, with several studies showing association with improved glycaemic control while others show no effect. Despite their high energy density and potential to contribute to weight gain, the authors’ review suggests that walnuts can contribute to satiety without association with weight gain. This review also suggests that walnut consumption has been associated with improved low-density lipoprotein cholesterol levels and endothelial function but has not been associated with blood pressure improvement. Meta-analyses are warranted to quantitatively assess impact of walnut consumption on these cardio-metabolic risk factors in T2DM.

Glycaemic control without weight gain in insulin requiring type 2 diabetes: 1-year results of the GAME regimen

2006 ◽  
Vol 8 (5) ◽  
pp. 517-523 ◽  
Author(s):  
H. de Boer ◽  
R. Keizers ◽  
M. Jansen ◽  
L. Verschoor ◽  
J. Ruineman-Koerts
Keyword(s):  
Type 2 Diabetes ◽  
Weight Gain ◽  
Glycaemic Control
Sign in / Sign up

Export Citation Format

Share Document